• Phoenix Rising needs funds to operate: please consider donating to support PR

FDA Approves Pitolisant for Daytime Sleepiness in Patients with Narcolepsy

pattismith

Senior Member
Messages
2,395
Likes
4,492
"Pitolisant, a first-in-class medication, is a selective histamine 3 (H₃) receptor antagonist/inverse agonist that increases the synthesis and release of histamine, a wake-promoting neurotransmitter in the brain. Pitolisant is administered orally once daily in the morning when a patient wakes up."